STOCK TITAN

Prospect Capital Corporation (PSEC) DEF 14A Filings

PSEC NASDAQ

Here are the DEF 14A proxy statements from Prospect Capital Corporation (PSEC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PSEC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PSEC filings page.

Rhea-AI Summary

Prospect Capital Corporation (PSEC) has called its 2026 virtual annual meeting for December 17, 2026, where only holders of its preferred stock will vote on one item: electing Class I director William J. Gremp to serve until the 2029 annual meeting and until his successor is elected and qualifies.

The record date is September 21, 2026, with 533,816,849 common shares and multiple preferred series totaling 67,598,002 preferred shares outstanding; each preferred share has one vote on this election, while common shares have no voting items. The board has five members, with a majority classified as independent under the 1940 Act and Nasdaq rules, and maintains Audit and Nominating/Corporate Governance/Compensation committees composed solely of independent directors.

Executive officers, including CEO John F. Barry III and President/COO M. Grier Eliasek, receive no cash compensation directly from PSEC, instead being paid by the external adviser and administrator, while independent directors each received $262,500 in total fees from the fund complex in fiscal 2026. Deloitte & Touche LLP remains the independent auditor, earning $1.89 million in audit fees for the year ended June 30, 2026. The company also discloses that it may, from time to time, repurchase outstanding common stock, preferred stock, or debt securities, consistent with applicable securities laws.

Rhea-AI Summary

Prospect Capital Corporation is calling a virtual special meeting of stockholders to vote on renewing its authorization, with Board approval, to sell common stock for the next 12 months at prices below its then-current net asset value (NAV) per share. Any sale on a given date would be capped at 25% of shares outstanding immediately before that sale.

The proxy explains that, as a business development company, Prospect relies on equity markets to fund investments and maintain required asset coverage ratios. Management argues that below-NAV sales, while immediately dilutive to existing holders, could provide capital to pursue investment opportunities and repay borrowings during periods when the stock trades at a discount to NAV. As of March 11, 2026, the last reported NAV per common share was $6.21 and the Nasdaq closing price was $2.66, a 57.2% discount.

The materials detail voting mechanics, quorum requirements, and examples showing how issuing shares at different discounts to NAV would dilute non-participating holders and, in some cases, slightly benefit those who buy more than their pro rata share. The Board unanimously recommends voting “FOR” the proposal.